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Abstract
Vitamin D is an essential nutrient that is metabolized in the body to generate an active 
metabolite (1,25(OH)2D) with hormone-like activity and highly diverse roles in cellular 
function. Vitamin D deficiency (VDD) is a prevalent but easily preventable nutritional 
disturbance. Emerging evidence demonstrates the importance of sufficient vitamin 
D concentrations during fetal life with deficiencies leading to long-term effects into 
adulthood. Here, we provide a detailed review and perspective of evidence for the role 
of maternal VDD in offspring long-term health, particularly as it relates to developmental 
origins of health and disease (DOHaD). We focus on the roles in neurobehavioral and 
cardiometabolic disorders in humans and highlight recent findings from zebrafish and 
rodent models that probe potential mechanisms linking early life VDD to later life health 
outcomes. Moreover, we explore evidence implicating epigenetic mechanisms as a 
mediator of this link. Gaps in our current understanding of how maternal VDD might 
result in deleterious offspring outcomes later in life are also addressed.
Introduction
Vitamin D is obtained through various plant and animal 
dietary sources and can also be synthesized in the skin 
through sunlight exposure (Fig. 1). All forms of vitamin D 
are metabolized in the liver via 25-hydroxylases to generate 
25 hydroxyvitamin D, 25(OH)D, the predominant but 
inactive circulating form of vitamin D. (Fig. 1). As shown, 
the kidney is the primary site of conversion of 25(OH)D to 
the active form 1,25(OH)2D via the 1-alpha-hydroxylase 
CYP27B1. However, extrarenal expression of CYP27B1 
also generates 1,25(OH)2D in numerous target tissues 
including the placenta and brain (Townsend et al. 2005, 
Adams & Hewison 2012). Vitamin D deficiency (VDD) is 
commonly defined as 25(OH)D concentration <50 nmol/L 
(Holick et  al. 2011) and represents one of the most 
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widespread but treatable nutrient deficiencies (Holick 
et al. 2011). VDD has been attributed to dietary depletion, 
insufficient sunlight exposure, adiposity and genetic 
variants (Ross 2011). Pregnant women are especially at 
high risk (Fiscaletti et  al. 2017), and global rates range 
from 7% in Southern Africa up to 100% in some parts 
of Northern Europe (Hossein-nezhad & Holick 2013). 
In the United States (US), up to 80% of pregnant 
women, including those prescribed prenatal vitamins, 
are estimated to have low vitamin D status (McAree et al. 
2013).
VDD during pregnancy is associated with increased 
risk of gestational diabetes and preeclampsia, which can 
indirectly affect offspring health (Bodnar et  al. 2007, 
Figure 1
Synthesis and functions of active hormonal 
vitamin D metabolite 1,25(OH)2D. As shown, the 
liver is essential in converting vitamin D to  
25(OH)D. Within the kidney, it is then further 
metabolized to 1,25(OH)2D, although it is 
increasingly being recognized that other organs 
can convert 25(OH)D to 1,25(OH)2D. Once formed, 
1,25(OH)2D can induce both genomic and 
non-genomic effects mediated by VDR, some of 
which are illustrated in this diagram. Adapted, 
under the terms of the original CC-BY licence, 
from Vuolo et al. 2012; and adapted by 
permission from Springer Nature, Journal of 
Pharmaceutical Investigation, Vitamin D in cancer: 
effects of pharmaceutical drugs on the vitamin D 
pharmacokinetics, Soo-Jeong Lim, So Hee Kim, 
copyright (2014) (Lim & Kim 2014). A full colour 
version of this figure is available at https://doi.
org/10.1530/JOE-18-0541.
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Brannon 2012, Senti et  al. 2012). It is also associated 
with direct effects on offspring health such as low birth 
weight, poor skeletal health, impaired brain development, 
autoimmune disease, obesity and insulin resistance 
(Krishnaveni et al. 2011, Crozier et al. 2012, Reichetzeder 
et  al. 2014, Hawes et  al. 2015, Gur et  al. 2016, Maia-
Ceciliano et  al. 2016). Recent randomized controlled 
trials involving vitamin D supplementation in high-risk 
pregnancies demonstrated decreased cesarean section rate 
and maternal hospitalization, decreased macrosomia and 
hospitalization in newborns of women with gestational 
diabetes (Karamali et al. 2016). Favorable effects on insulin 
metabolism parameters, serum HDL cholesterol and total 
cholesterol concentrations in women with pre-eclampsia 
risk factors were also reported (Karamali et al. 2015).
Maternal VDD likely impacts offspring health 
by altering fetal and newborn vitamin D availability. 
Although 1,25-dihydroxyvitamin D [1,25(OH)2D], the 
primary bioactive form, does not readily cross the placenta, 
umbilical cord concentrations of its precursor, 25(OH)D, 
are similar to maternal concentrations (Hillman & Haddad 
1974, Fleischman & Cole 1980, Gray et al. 1981, Marshall 
et al. 2013). Findings from a recent human study provide 
evidence that the placenta, working as the interface 
between mother and fetus, modulates circulating vitamin D 
metabolites in pregnant women and that it favors the 
uptake of DBP-bound 25(OH)D3 through a specific 
receptor system (LRP2-CUBN) (Park et  al. 2017). In the 
placenta, CYP27B1 activity is detectable in both maternal 
decidua and fetal trophoblast, which then allows for local 
production of 1,25(OH)2D from maternal 25(OH)D via 
1-alpha-hydroxylase (Ganguly et al. 2018). Likewise, both
decidua and trophoblast also express VDR (Liu & Hewison
2012). Placental production of 1,25(OH)2D is proposed to 
be essential for immunosuppressive effects required for 
immune tolerance of implantation. However, ex vivo and 
in vitro studies provide evidence for a more extensive role of 
vitamin D in placental function, including trophoblastic 
differentiation and extravillous trophoblast invasion of 
the decidua and myometrium (Ganguly et al. 2018).
Studies are ongoing to better understand the potential 
genomic and non-genomic mechanisms responsible for 
effects of maternal VDD on offspring health (Fig.  1). 
Vitamin D has both calciotrophic and noncalciotrophic 
functions (Maalouf 2008). It plays a major role in 
calcium ion homeostasis by regulating calcium transport 
and bone mineralization. Noncalciotropic functions of 
vitamin D occur via vitamin D receptor (VDR) activity 
in many tissues across the body. 1,25(OH)2D acts as 
a nuclear receptor ligand primarily binding to the 
vitamin D receptor (VDR) – retinoic X receptor (RXR) 
complex to activate or repress gene transcription at 
vitamin D response elements across the genome 
(Fig.  1). The calciotropic function of vitamin D does 
not sufficiently explain all the adverse effects of VDD 
on offspring health since calcium absorption during 
pregnancy is increased in an estrogen-dependent and 
vitamin D-independent manner in vitamin D receptor 
(VDR)-knockout mice (Heaney & Skillman 1971, 
Van Cromphaut et  al. 2003, Fudge & Kovacs 2010). 
Additionally, maternal–fetal calcium transfer in both 
VDD rats and VDR-knockout mice is unaffected (Glazier 
& Sibley 1995, Kovacs et  al. 2005). Thus, VDD-related 
offspring health outcomes are likely in part due to non-
calciotropic functions of vitamin D. However, whether 
these are direct vs indirect effects and mediated by VDR 
genomic activity remains unclear.
Recently, the focus on the relationship between 
maternal VDD and long term offspring health has 
shifted to roles of vitamin D as a regulatory agent in 
‘fetal programming’ of disease in later life, also termed 
developmental origins of health and disease (DOHaD) 
(Brannon 2012, Reichetzeder et  al. 2014, Chango & 
Pogribny 2015). Animal models have been designed to 
elucidate the DOHaD effects of this secosteroid hormone 
nutrient. The purpose of this review is to discuss the 
findings, strengths and limitations of DOHaD-focused 
VDD studies in current and emerging rodent and 
zebrafish models, primarily as they relate to human 
metabolic and neurobehavioral health. We also discuss 
emerging evidence of epigenetic activity of vitamin D and 
implications of a mechanistic role in DOHaD.
Neurobehavioral health
Recent findings link low vitamin D status to adverse 
neurological outcomes such as autism spectrum disorder 
(ASD), schizophrenia, depression, multiple sclerosis 
and dementia (Eyles et al. 2011, 2013, Yates et al. 2018). 
Accumulating evidence suggests that vitamin D is 
metabolized in various cells within the central nervous 
system, such as glial cells, neurons and astrocytes (Cui 
et  al. 2017). 1,25(OH)2D genomic activity is responsible 
for activating transcription of genes critical for early 
brain development (Eyles et al. 2011). VDR’s regulation of 
the dopaminergic system implicates a direct association 
with neurodegenerative diseases (Stednitz et  al. 2015). 
Low vitamin D status, at early developmental stages and 
throughout adulthood, results in impaired dopamine 
(DA) turnover (Kesby et  al. 2009, Pertile et  al. 2016). 
Impaired DA turnover can cause oxidative stress, neuron 
degradation and hyperactivity (Beninger 1983, Nowicki 
et al. 2015, Takeshima et al. 2016). Given the essential role 
of vitamin D in promoting healthy brain development, 
VDD has been proposed as a contributing factor to 
neurobehavioral health outcomes such as ASD and 
attention deficit hyperactivity disorder (ADHD) (Berridge 
2018, El-Ansary et al. 2018).
Human studies
Autism and ADHD
In an extensive epidemiological study, Childhood 
Autism Risks from Genetics and the Environment 
(CHARGE) showed an association between autism 
spectrum disorders (ASDs) and several functional 
polymorphisms in genes within the vitamin D pathway, 
including Bsm1, Taq1, Cdx2 and FokI in the vitamin D 
receptor (VDR) gene (Schmidt et al. 2015). Importantly, 
this study pinpointed that the genotype AA/A-allele of 
GC rs4588, encoding the vitamin D-binding protein, was 
strongly associated with ASD in children (Schmidt et al. 
2015). Additionally, supplementation with high doses 
of vitamin D (ranging from 300 IU/kg/day to 5000 IU/day) 
in two open-label trials has been found to improve 
clinical core symptoms of autism in ~75% of affected 
children (Cannell 2017).
Assessment of the Generation R study, a population-
based cohort of mother–child dyads (n = 4229) from 
Rotterdam, The Netherlands, revealed that gestational 
VDD (defined by the study as maternal 25(OH)D 
<25 nmol/L) was associated with an increase in autism-
related traits in 6-year-old offspring (Vinkhuyzen et  al. 
2018). Analogous findings were reported with a birth 
cohort that included 4334 individuals where mid-
gestational VDD was associated with increased risk of 
ASD (Vinkhuyzen et al. 2018). A prospective study with 
1650 mother–children pairs included as part of the INMA 
Project (Spain 1997–2008) assessed maternal 25(OH)D 
concentrations in relation to child ADHD-like symptoms 
(attention deficit and hyperactivity-impulsivity) evaluated 
using the ADHD Criteria of Diagnostic and Statistical 
Manual of Mental Disorders fourth edition form. It was 
found that increasing maternal 25(OH)D concentrations 
were linked with a lower risk of ADHD-like symptoms in 
resulting children (Morales et al. 2015).
Other neurological disorders
Assessment of later receptive language ability in children 
aged 5 and 10 born to Caucasian women in Perth, Western 
Australia discovered that maternal VDD (≤46 nmol/L 
of 25(OH)D) during pregnancy was associated with 
higher incidence of later language difficulties in children 
(Whitehouse et al. 2012). It has also been hypothesized that 
maternal VDD during pregnancy may increase offspring 
risk for later adult-onset schizophrenia (McGrath 1999). 
Two studies, Finnish Maternity Cohort and the Nurses’ 
Health Study II, collectively sampled ~ 36,000 mothers 
and identified a positive link between maternal VDD and 
risk of adult offspring developing multiple sclerosis (MS) 
(Mirzaei et al. 2011, Munger et al. 2016).
Polymorphisms in vitamin D pathway genes such 
as VDR have been shown to affect binding to calciferol 
and contribute to VDD (Zumaraga et al. 2017). Therefore, 
several studies have also assessed the link between MS and 
genetic variants in vitamin D pathway genes. However, 
not all reports agree. A study of Canadian MS patients 
and unaffected relatives did not detect any significant 
associations between vitamin D pathway genetic 
variants that were previously linked to serum 25(OH)D 
concentrations and disease status (Orton et  al. 2011). A 
meta-analysis with 303 Caucasian Spanish MS patients 
and 310 healthy Caucasian Spanish controls also did not 
find any association with VDR variants rs2228570 (Fok1) 
or rs731236 (Taq1) and risk of MS (García-Martín et  al. 
2013). In contrast, another study that examined 726 MS 
patients and 604 controls from the United Kingdom (UK) 
found that the VDR Taq1 polymorphism rs731236 was 
associated with MS such that there was overrepresentation 
of the minor allele (C) in MS patients (Cox et al. 2012). 
This latter study also suggested a trend of increasing risk 
for MS specifically in individuals homozygous for the 
HLA-DRB1*501 allele in association with the Fok1 allele 
known to generate a more active form of VDR. Genetic 
variants in CYP27B1, which catalyzes the conversion 
of 25(OH)D to 1,25(OH)2D, have also been linked with 
MS susceptibility. A genome-wide association study 
performed with 1618 MS patients of European ancestry 
from Australia and New Zealand and 3412 controls of 
European ancestry from the UK and US found alleles 
at the CYP27B1 variant rs703842 were associated with 
increased risk of MS (Australia and New Zealand Multiple 
Sclerosis Genetics Consortium (ANZgene) 2009). Alleles at 
rs703842 were associated with circulating 25(OH)D levels 
in a study comparing twins concordant or discordant for 
MS (Orton et al. 2008).
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Rodent models
Rodent models of VDD during pregnancy reproduce 
the human condition by depleting the maternal diet of 
vitamin D and establishing an in utero environment 
deficient in vitamin D. Mouse dams were fed diets lacking 
vitamin D (0 IU/g of vitamin D) or gradient levels of reduced 
vitamin D (described below) to induce VDD during critical 
windows of pre- and perinatal development. VDD effects 
were assessed by comparing mice on VDD diet to mice on 
vitamin D-sufficient diets. The exact amount of vitamin D 
in sufficient diets varies by diet. Various rodent strains 
have been tested depending on the phenotype of interest 
to be examined. Outbred (not genetically identical) strains 
such as Sprague–Dawley rats, Wistar rats or Swiss Webster 
mice were presumably used to maximize phenotypic 
robustness, while genetically identical (inbred) mouse 
strains such as C57BL/6, BALB/c or BTBR were likely 
used to ensure biological reproducibility. Strains from 
recombinant inbred mouse lines such as the Collaborative 
Cross (CC) both maximize phenotypic robustness and 
ensure reproducibility (Churchill et  al. 2004). Lines 
carrying targeted/naturally occurring genetic mutations in 
genes of interest have also been used to elucidate effects of 
specific genetic changes in response to VDD.
Learning and memory
Progeny of VDD C57BL/6J dams exhibited later in life 
impairments in learning and memory, as assessed by 
an olfactory-based test and smaller lateral ventricles 
(Fernandes de Abreu et al. 2010). Pre- and post-natal VDD 
increased learning and memory deficits and resulted in 
elevated depressive-like and anxiety-like behaviors in male 
mice (Fu et al. 2017). Similar learning and memory deficits 
were reported in male rats subjected to VDD during the 
perinatal period (Yates et  al. 2018). Deviations in pup 
ultrasonic vocalizations reduced social behaviors, and 
an increase in stereotypical behaviors was also detected 
in this group, which might be attributed to reduced 
maternal care provided by VDD dams. One report, 
however, suggests inbred mice differ in prenatal VDD 
effects on later neurobehavioral disruptions (Langguth 
et al. 2018). Assessment of the effect of prenatal VDD on 
autism-related behaviors (ultrasonic vocalizations, social 
interaction, hyperlocomotion, grooming, rearing and 
spatial learning and memory) in several inbred mouse 
models demonstrate significant differences between 
strains for the behaviors examined (Langguth et al. 2018). 
For example, the C57BL/6J strain and (C57BL/6J × BTBR)
F1 hybrid strain were seemingly susceptible to 
prenatal VDD, while the BALB/c and BTBR mice were 
less so. C57BL/6J offspring exhibited decreased preference 
for novel social interactions and the F1 offspring exhibiting 
hypolocomotive behavior when tested in an open field 
test (Langguth et al. 2018). Such behavioral deficits though 
were absent in the other two strains. The collective data 
suggest offspring sex and genotype can interact with 
prenatal VDD to influence later neurobehavioral outcomes, 
including cognitive and social impairments.
Neuro-affective disorders
Juvenile progeny of VDD Sprague–Dawley rat dams 
treated from mating until weaning showed heightened 
anxiety-like behaviors, as measured by significantly 
increased grooming frequency compared to other groups 
when tested in the elevated plus maze (EPM, measures 
anxiety-like and exploratory behaviors) (Pan et  al. 
2014). Interestingly, juvenile offspring of dams provided 
an excessive vitamin D diet (10.0 IU/g) also showed 
significantly increased grooming frequency during social 
behavior and learning tests (Pan et  al. 2014). Effects of 
maternal VDD on anxiety-related behavior appear to 
be independent of the hypothalamic-pituitary-axis 
(HPA) with one study showing normal function in rats 
born to VDD dams (Eyles et al. 2006). Instead, the fetal 
mesencephalon and dopaminergic neurons might be 
affected by Nurr1 and p57Kip2 expression reduced in this 
brain region of this group (Cui et al. 2010).
Emerging zebrafish models
Initial evidence of a canonical role for VDR and the 
vitamin D endocrine system in calcium ion homeostasis 
and skeletal maintenance has been demonstrated for some 
teleost species (Eyles et al. 2005). It is likely that aquatic 
vertebrates also exhibit non-calcemic roles of vitamin D, 
including induction of xenobiotic metabolism, regulation 
of cell proliferation and differentiation, regulation of 
neurodevelopment and immune system function (Nagpal 
et al. 2005, Kollitz et al. 2016). Most teleost species express 
two distinct VDR paralogs (VDRα and VDRβ) (Howarth
et al. 2008). These receptors exhibit similar functionality 
to mammalian VDRs, having high-affinity ligand 
binding and potent receptor transactivation efficacies 
with 1,25(OH)2D and lithotomic acid as ligands (Kollitz 
et al. 2016).
Emerging zebrafish models of VDD during 
development pose as valuable tools to study the 
effects of VDD on neurobehavioral health. Small 
fish models offer unique advantages over traditional 
rodent models, including low maintenance and 
husbandry costs, high fecundity and ease of developing 
genetic mutants with the added benefit of reduced animal 
welfare concerns (Planchart et  al. 2016). In this regard, 
the zebrafish model has become a highly utilized animal 
model for investigating molecular mechanisms of 
neurodevelopment, cardiovascular disease and obesity.
With regards to neurodevelopment, zebrafish models 
can be used to assess important behavioral phenotypes 
due to their well-defined behavioral responses at larval 
and adult stages, skin transparency during embryonic and 
early larval developmental stages and a large number of 
genetic mutants available for testing (Norton 2013). More 
importantly, since zebrafish have external fertilization 
and development, a DOHaD zebrafish model of VDD 
will specifically allow for dissecting important effects 
of embryonic and early developmental VDD that are 
independent of maternal metabolism.
Metabolic health
Human studies of later life effects of VDD
In 2012, the WHO estimated that 2.8 million deaths were 
attributable to obesity and its metabolic sequelae every 
year (World Health Organization 2017). Although the 
etiology of obesity is often simplified as an issue of excess 
caloric intake, there is mounting evidence that in utero 
environment can determine offspring susceptibility to 
obesity and related metabolic complications in later life 
(Saffery & Novakovic 2014).
There is no universally accepted definition of the 
broad term ‘metabolic health’, however, a combination 
of assessment criteria including measurements of body 
weight/composition, blood pressure, serum lipid profile, 
insulin resistance (IR) and systemic inflammation 
are frequently used for clinical and research purposes 
(Phillips & Perry 2013). When using these criteria as 
terms in searching the existing literature, there exists only 
a paucity of data on the influence of maternal VDD on 
offspring metabolic health beyond the neonatal/first year 
of life. The findings are mixed but provide some evidence 
for a relationship between poor maternal vitamin D status 
and abnormal metabolic health outcomes such as excess 
adiposity and insulin resistance.
In the Southampton Women’s Survey of 977 pregnant 
women and their offspring, lower pregnancy 25(OH)D 
concentrations were significantly linked to higher fat 
mass assessed at 6  years of age (Crozier et  al. 2012). 
Similarly, findings from the Amsterdam Born Children and 
their Development (ABCD) study of 1882 mother–child 
pairs observed an inverse relationship between maternal 
25(OH)D and offspring percent body fat at 5  years of 
age (Hrudey et  al. 2015). This same study also showed 
inverse associations between maternal 25(OH)D and 
markers of IR in children whose mothers were overweight 
during pregnancy (Hrudey et al. 2015). Maternal VDD in 
another large birth cohort involving Indian 
children likewise predicted higher IR at 9.5  years old 
(Krishnaveni et al. 2011).
Not all cohort data support a connection between 
pregnancy vitamin D status and metabolic health. In a 
longitudinal prospective UK study, a weak inverse associa-
tion was detected between circulating 25(OH)D concentra-
tions during pregnancy and offspring C reactive protein 
measured in childhood and adolescence (Williams et  al. 
2013). However, no consistent associations were detected 
between pregnancy serum 25(OH)D concentrations and 
serum lipids, fasting glucose or fasting insulin at either 
time point (Williams et al. 2013). Neither the Danish D-Tect 
Case-Cohort Study or the 1988–89 Danish Cohort Study 
found associations between 25(OH)D concentrations 
at birth and risk of being overweight at 7  years of age 
(Jensen et  al. 2017) or associations between maternal 
25(OH)D and offspring cardio-metabolic risk factors 
(body weight, serum lipids, inflammatory markers and IR) 
in a 20-year follow-up (Rytter et al. 2016).
Metabolomic evidence from a randomized  
controlled trial
Recently, metabolomic data were used to identify 
downstream metabolites that are influenced by or 
interact with 25(OH)D (Blighe 2017). They used 
metabolomic data from 3-year olds enrolled in the 
Vitamin D Antenatal Asthma Reduction Trial (VDAART) 
(Litonjua et  al. 2014). They identified three distinct 
subsets/clusters of biologically meaningful metabolic 
profiles that were distinguished by concentrations 
of inflammatory mediators (predominantly fatty 
acids and amines) and maternal vitamin D status 
postsupplementation. Individuals either had (1) high 
fatty acids, high amines and low maternal vitamin D 
status; (2) high amines, intermediate fatty acids and 
normal maternal vitamin D status or (3) low fatty acids 
and amines and normal maternal vitamin D status 
(Blighe 2017). Importantly, maternal vitamin D status 
had a significant influence on cluster membership. This 
finding suggests in utero vitamin D exposure may be an 
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important predictor of susceptibility to inflammation 
and other undesirable metabolic disorders later in 
life (Blighe 2017).
Important considerations
Maternal weight and fetal growth must be considered in 
the interpretation of offspring metabolic data collected 
later in life. Maternal obesity is an independent risk 
factor for the development of obesity and other metabolic 
complications in offspring later life (Gaillard 2015, 
Maffeis & Morandi 2017). Furthermore, pregnant women 
with excess adiposity are more likely to exhibit VDD as 
there is a well-established inverse association between 
body fat mass and serum 25(OH)D concentrations 
(Lagunova et al. 2009, Delle Monache et al. 2019). Thus, 
characterizing metabolic health effects of maternal 
obesity vs those of maternal VDD is confounded and 
appears to depend on the outcomes examined. The ABCD 
study found that only the offspring of overweight women 
exhibited an association between low maternal 25(OH)D 
(<29.9 nmol/L) and increased insulin resistance, and there 
were no interactive effects of pre-pregnancy BMI in the 
association between low maternal 25(OH)D and increased 
% body fat in offspring (Hrudey et al. 2015).
One theme dominating the literature on maternal 
VDD is its influence on fetal growth. Although, the 
specific effects of maternal VDD on fetal growth are 
dependent on the severity and timing of the deficiency, 
the preponderance of data show VDD is associated with 
decreased birth weight and higher risk for ‘small for 
gestational age’ (SGA) (Leffelaar et  al. 2010, Burris et  al. 
2012, Schneuer et  al. 2014, Eckhardt et  al. 2015, Miliku 
et  al. 2016, Bi et  al. 2018). This influence complicates 
the interpretation of results examining the prenatal 
programming effects of maternal VDD since fetal growth 
restriction, regardless of its origin, and its subsequent 
‘catch-up’ weight gain are also well known to be related to 
metabolic health complications (Hales & Ozanne 2003). 
Thus, the application of animal models can be quite 
useful in elucidating these complex relationships (Hales 
& Ozanne 2003).
Rodent models
Support for the role of maternal VDD in fetal programming 
of later metabolic disorders has been documented in 
several studies using rodent models subjected to in utero 
VDD (Reichetzeder et  al. 2014). The majority of these 
investigations show that offspring of mothers with low 
serum 25(OH)D during pregnancy present with abnormal 
metabolic phenotypes later in life most commonly 
increased fat mass, insulin resistance, hypertension 
and/or altered fat metabolism.
In one of the earliest transgenerational mouse 
vitamin D fetal programming studies, compared with 
controls, 6-month-old F1 generation offspring of VDD 
dams displayed greater body and epididymal fat mass 
(Nascimento et al. 2013). These mice also had increased 
insulin secretion when given an oral glucose challenge and 
showed marked hepatic steatosis. An in utero VDD Sprague-
Dawley rat model expanded these findings showing a 
positive correlation between serum inflammatory markers 
and HOMA-IR in adult (16-week-old) offspring, suggesting 
that IR might be a result of persistent inflammation 
(Zhang et al. 2014). Furthermore, the finding that progeny 
of VDD C57BL/6 dams exhibited impaired pancreatic 
development (smaller) and islet structure (smaller with 
diminished beta cell mass although overall morphology 
remained intact) and reduces insulin secretion, suggests 
that impaired insulin sensitivity in VDD offspring is due 
to alterations in structure and metabolism of the pancreas 
(Maia-Ceciliano et al. 2016). In support of this conclusion, 
VDD offspring exhibited a decrease in protein expression 
of PDK-1, an essential mediator of insulin-signaling in 
beta-cells (Maia-Ceciliano et al. 2016).
1,25(OH)2D is well known to inhibit the renin-
angiotensin system through suppression of renin 
secretion in the kidney (Li et al. 2002) and in pancreatic 
islets (Cheng et  al. 2011). However, there are limited 
data available on the effects of maternal VDD on kidney 
function. A few rodent studies show elevation in blood 
pressure in adult offspring of VDD dams (Nascimento et al. 
2012, Meems et al. 2016). This increased blood pressure 
in progeny of VDD Swiss Webster dams was shown to 
be related to significant changes in kidney development 
(poor maturation of glomeruli) and decreased expression 
of the podocin protein, a key component of the renin-
angiotensin system (Nascimento et al. 2012). Remarkably, 
both the F1 generation and F2 generation were negatively 
affected by maternal VDD (F0 generation). Alternatively, 
a Sprague–Dawley rat model demonstrated that increased 
susceptibility for hypertension in offspring of VDD 
parents is linked to impaired endothelial relaxation in the 
large vessels and that reduced Panx1 gene expression may 
contribute to the observed loss of endothelial relaxation 
(Meems et al. 2016).
Another condition related to maternal VDD and 
metabolic disturbances in offspring is nonalcoholic fatty 
liver disease (NAFLD) (Hyppönen & Boucher 2018). 
Since both vitamin D status and NAFLD are associated 
with excess adiposity and IR, interest in examining their 
potential links has grown. This interest has extended 
into potential DOHaD effects. A recent study used a VDD 
Wistar rat model to explore this area. F1 generation adult 
(34 weeks old) female offspring exhibited severe hepatic 
steatosis, abnormal lipid metabolism, increased markers 
of inflammation and oxidative stress and downregulation 
of hepatic Ppara and Ucp2 expression (Sharma et  al. 
2017). Interestingly, male F1 offspring were affected to a 
lesser extent with only mild hepatic steatosis but showed 
similar downregulation of Ucp2 and the positive regulator 
of oxidative stress superoxide dismutase 1 (Sod1), 
demonstrating sex differences.
Adipogenesis and DOHaD effects
There is evidence that in utero adipogenic programming 
may be associated with obesity later in life (Desai & Ross 
2011). In most mammals, including humans, adipose 
tissue forms throughout the lifespan (Rosen et al. 2000). 
Adipogenesis during fetal development is a complex, 
yet tightly regulated process involving the proliferation 
and differentiation of progenitor cells into preadipocytes 
(vs other cell types such myocytes), and eventually into 
mature adipocytes when stimulated (Desai et  al. 2013). 
Perturbations to the intrauterine environment caused 
by suboptimal maternal nutrition (e.g. restricted energy 
and protein intakes) have been shown to lead to dramatic 
DOHaD effects on this process (Li et al. 2010). The specific 
consequences of maternal VDD, however, are largely 
unclear and contradictory, although the importance of 
VDR signaling in adipogenesis is undeniable as VDR-
knockout mice exhibit drastic changes in adipose tissue 
development including reduced adiposity and resistance 
to diet-induced obesity (Narvaez et  al. 2009). Moreover, 
1,25(OH)2D has been shown to influence several key 
adipogenic genes and transcription factors (Ding et  al. 
2012). Our lab recently completed a mouse study on the 
molecular mechanisms by which maternal VDD might 
influence adipose tissue in offspring (Belenchia et  al. 
2017). In that analysis, relative to controls, 19-week-old 
male mice born to VDD dams experienced rapid weight 
gain in the early weeks post weaning and acquired a 
higher proportion of body fat as depots associated with 
metabolic complications (visceral fat). Additionally, 
offspring of VDD dams also had higher expression of 
perigonadal adipose Pparg, a transcript with integral roles 
in adipogenesis and lipid storage.
Interestingly, a recent VDR-knockout study report 
did not support a fundamental role for vitamin D in 
adipogenesis (Schutkowski et  al. 2018). While VDR 
knockouts represent a valuable genetic model of 
completely obliterated genomic vitamin D activity, these 
models may not recapitulate the consequences of diet-
induced VDD, which better mimic human VDD with loss 
of both genomic and non-genomic effects, allowing also 
for potential physiological adaptations to low vitamin D 
provision (Narvaez et al. 2009, Kong et al. 2013, Narvaez 
et  al. 2013). Therefore, caution should be exercised in 
comparing dietary and genetic models of VDD including 
systemic depletion, KO or disruption of any gene involved 
in vitamin D metabolism, transport or function.
Emerging zebrafish models
A putative relationship between vitamin D and obesity in 
zebrafish has recently been investigated using a cyp2r1−/− 
mutant line (Peng et al. 2017). Cyp2r1 is a liver microsomal 
hydroxylase essential for the conversion of vitamin D 
into 25(OH)D. Human genetic variants in CYP2R1 have 
been correlated with serum 25(OH)D concentrations in 
recent genome-wide association studies (Ahn et al. 2010, 
Wang et al. 2010). Deficits in this metabolic conversion 
would be expected to limit serum levels of 1,25(OH)2D 
since 25(OH)D is the direct precursor. However, despite 
a >50% reduction in circulating 25(OH)D concentrations 
in mouse Cyp2r1−/− mutants, 1,25(OH)2D levels in 
Cyp2r1−/− mutants were seemingly unaffected and mice 
were relatively healthy (Zhu et  al. 2013). This finding 
strongly implicates additional contributors to this 
metabolic step in vitamin D activation. Additionally, 
there are likely localized and tissue-specific differences in 
1-alpha-hydroxylase activities that may impart specified
paracrine or autocrine functionalities like those observed
in human brain pericytes and the epidermis which exhibit
functionally active CYP2R1 enzyme activities (El-Atifi 
et al. 2015, Christakos et al. 2016).
In contrast to the mouse Cyp2r1−/− mutants, zebrafish 
cyp2r1−/− mutants exhibited an almost 70% reduction in 
circulating 1,25(OH)2D that was completely rescued by 
25(OH)D treatment (Peng et al. 2017). Zebrafish cyp2r1−/− 
mutants also exhibited an obesity-like phenotype with 
increased central adiposity (e.g. visceral fat). However, no 
significant differences in liver triglyceride concentrations, 
bone density or bone volume were observed (Peng 
et  al. 2017), likely due to the incomplete depletion of 
1,25(OH)2D. While these studies do suggest that vitamin D 
insufficiency may precede obesity, a causal mechanism 
has not been established. The ability of vitamin D to 
impact both preadipocytes and mesenchymal stem 
cells differentiation toward adipocytes may be one 
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putative mechanism; however, there are conflicting 
results on the pro or anti-adipogenic effects of vitamin D 
depending upon the model utilized (Abbas 2017). Differing 
effects of VDD on obesity between the mouse Cyp2r1−/− 
and zebrafish cyp2r1−/− mutant models highlight the value 
of assessing and comparing multiple animal models of 
VDD for the purpose of understanding human health.
Evidence for the role of 
epigenetic mechanisms
Epigenetic regulation of the genome through changes in 
DNA and histone modifications and noncoding RNA is 
an essential component of fetal development, and both 
the non-genomic and genomic actions of vitamin D can 
affect such responses. During development, dynamic 
changes in epigenetic markers such as DNA methylation, 
DNA hydroxymethylation, posttranslational covalent 
modifications (e.g. addition of methyl or acetyl groups to 
histone residues) and numerous types of short and long 
RNAs regulate the transcriptional activity of genes as cells 
acquire specific functions. Although select epigenetic 
marks are malleable throughout development, a subset 
of epigenetic states is programmed early on and stably 
maintained into adulthood. These epigenetic programs 
regulate essential cellular functions including cell 
metabolism, survival, proliferation and activity (Hemberger 
et al. 2009). Environmental dysregulation leading to the 
inability to establish or maintain these essential stable 
epigenetic programs has significant implications for long-
term health outcomes (Walker & Ho 2012, Martinez et al. 
2015, Chen et al. 2016, Faa et al. 2016).
The role of diet in modulating epigenetic state 
is well documented. Individual nutrients can act as 
donors of epigenetic markers, cofactors of epigenetic 
regulatory enzymes and signaling molecules of epigenetic 
regulation of transcription (Ideraabdullah & Zeisel 
2018). Epigenetic dysregulation as a result of maternal 
restriction of individual macro- and micro-nutrients has 
been demonstrated (Ideraabdullah & Zeisel 2018). In 
some cases, this affects multiple generations (Wolff et al. 
1998, Radford et al. 2014, Nowacka-Woszuk et al. 2018). 
Developing research shows that maternal vitamin D status 
during pregnancy may determine offspring epigenetic 
state although whether there are specific windows of 
susceptibility has not been examined. As illustrated in 
Fig.  2, VDD-induced epigenetic dysregulation during 
development represents a potential mechanistic link 
between maternal VDD and long-term offspring health.
Human studies
Human studies measuring the relationship between 
maternal vitamin D status and offspring epigenetic states 
have had differing results. A study performed in cohorts 
from Norway and the United Kingdom failed to find 
significant associations between maternal vitamin D 
status during the second trimester and cord blood DNA 
methylation at birth (Suderman et  al. 2016). However, 
a more recent case/control study of a Midwestern US 
cohort, reported that maternal supplementation with 
vitamin D (3800 IU/day vs 400 IU/day) during pre- and 
post-natal fetal development (starting in the second 
trimester) resulted in numerous DNA methylation 
changes in infant leukocytes (Anderson et al. 2018). These 
changes localized to genes involved collagen metabolism, 
apoptosis, lung and bone development and immune 
function including loss of DNA methylation at HLA-A, 
an antigen of the major histocompatibility complex 
(Anderson et  al. 2018). The differences in outcome 
between these two studies are possibly due to study design 
(supplemented vs basal serum vitamin D concentrations, 
geographical population, cell type assessed and cohort 
size) or differences in VDD prevalence within the cohort. 
While the Suderman et  al. (2016) study reported mean 
serum 25(OH)D concentrations well within the currently 
recommended levels of sufficiency (73.5 ± 23.42 ng/mL 
and 68.3 ± 32.3 ng/mL), Anderson et  al. (2018) reported 
much lower mean serum 25(OH)D concentration that 
decreased for control mothers (32.4 ng/mL–21.9 ng/mL 
postpartum) and subtly increased for supplemented 
mothers (31.4 ng/mL–36 ng/mL postpartum).
Association between maternal VDD and offspring 
epigenetic status at imprinted genes was also assessed 
recently in humans. Imprinted genes play vital roles in 
pre- and post-natal development and health (including 
growth, adiposity and brain development). Assessment 
of mother–infant dyads in the Newborn Epigenetics 
Study (NEST) study cohort found that maternal 25(OH)D 
status measured in the first or second trimester was 
inversely associated with birthweight z-scores and 
positively associated with 1-year-old weight-for-length 
and three-year-old BMI z-score (Neelon et  al. 2018). 
However, no significant association was detected between 
maternal 25(OH)D concentrations and cord blood DNA 
methylation levels at imprinted genes H19, IGF2, MEG3, 
MEG3- IG, MEST, NNAT, PEG3, PLAGL1 and SGCE/PEG10 
(Neelon et al. 2018).
These studies were limited to easily accessible 
biospecimens like maternal, infant or cord blood. 
Interpreting biological relevance of blood epigenetic 
changes is challenging due to wide variation in cell 
composition and often hampered by the lack of specific 
relevance to physiologically affected tissues. Animal 
models represent a valuable research tool, allowing 
for a controlled environment and precise dietary 
manipulation including assessment of discrete exposure 
windows and collection of tissues/cells from progressive 
developmental stages.
Rodent models
One of the earliest studies in rodents reported that 
progeny of VDD Sprague–Dawley dams exhibited a 
significant increase in global DNA methylation in adult 
liver (Zhang et al. 2014). This corresponded with changes 
in expression of DNA methyltransferases (Dnmt1, Dnmt3a 
and Dnmt3b) and glycemic dysregulation including 
lower glucose tolerance, lower insulin sensitivity and 
higher levels of hepatic markers of inflammation (Zhang 
et  al. 2014). Further examination implicated the role of 
epigenetically regulated decreases in mRNA and protein 
levels of nuclear factor κB inhibitor α (IκBα, a key regulator
of NFκB-mediated inflammation) (Zhang et al. 2014).
A later epigenome-wide DNA methylation study 
in Sprague–Dawley rats found that offspring of VDD 
dams exhibited differential methylation in adipose 
tissue at >800 loci linked to 305 genes (Wen et al. 2018). 
Differential expression was detected at 141 of the 
differentially methylated genes, including two validated 
lipid metabolism genes, Vldlr and Hif1α. These epigenetic
and transcriptional changes were linked to obesity- 
and metabolic dysfunction-related phenotypes in the 
offspring (Wen et  al. 2018). A separate epigenome-wide 
DNA methylation study also in Sprague–Dawley rats 
reported that progeny of VDD dams exhibited differential 
methylation at ten genes in the kidney including gain of 
methylation at Pannexin-1, Panx1, which is abundantly 
Figure 2
Model of in utero VDD-induced epigenetic effects on long-term health outcomes in offspring. Potential pathway of events connecting maternal vitamin D 
deficiency to offspring health outcomes via epigenetically regulated organ/tissue dysfunction. Decreased availability of maternal 25(OH)D leads to 
decreased 25(OH)D entering the placenta and thus decreased availability of the 1,25(OH)2D required for genomic (VDR) and non-genomic signaling 
responses in the fetus. Consequently, fetal VDD potentially disrupts epigenetic programming during development of target organs/tissues such as brain, 
liver and adipose tissue. Dysregulated epigenetic programming leads to long term altered epigenetic states, which as shown, can disrupt genomic 
accessibility of regulatory machinery and downstream gene expression resulting in adverse long-term health outcomes in offspring, including 
neurobehavioral and metabolic disorders. A full colour version of this figure is available at https://doi.org/10.1530/JOE-18-0541.
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expressed in heart, skeletal muscle and vasculature (Meems 
et al. 2016). No corresponding change in Panx1 expression 
was detected in kidney, however, expression was altered 
in aorta but without any corresponding change in DNA 
methylation.
Our work recently showed that VDD in the mouse 
during gestation and lactation, followed by vitamin D 
sufficient diet at weaning, resulted in DNA methylation 
changes at imprinted loci across two generations (Xue 
et  al. 2016). Furthermore, by comparing offspring from 
reciprocal crosses of inbred collaborative cross strains 
(CC001/Unc and CC011/Unc), we also showed that this 
effect is likely dependent on the maternal strain (Xue 
et  al. 2016). For reciprocal crosses, Cross 1 mice were 
generated by mating CC001 dams to CC011 sires, while 
Cross 2 mice were generated by mating CC011 dams to 
CC001 sires. Thus, the maternal genomes and associated 
uterine environmental conditions differ between crosses, 
but the offspring are genetically identical (except at 
mitochondrial DNA and Y chromosome). First-generation 
offspring from Cross 1 exhibited loss of methylation at 
H19/Igf2ICR and Grb10DMR in liver and the latter was 
correlated with increased bodyweight. However, the 
genetically identical reciprocal cross (Cross 2) offspring 
showed no change in bodyweight or methylation at 
H19/Igf2ICR and Grb10DMR, but instead showed loss of 
methylation at IG-DMR in sperm (Xue et al. 2016). It will 
be important to determine whether the parent of origin-
dependent outcomes are due to an imprinted effect or a 
maternal effect and whether bodyweight and adiposity 
changes are linked to subsequent metabolic dysfunction.
Ex vivo models
The impact of vitamin D status on epigenetic mechanisms 
beyond DNA methylation has been explored mainly 
in cell culture. 1,25(OH)2D is proposed to interact with 
and modulate the activity of epigenetic regulatory 
proteins including chromatin remodeling complexes 
and histone-modifying enzymes (Fetahu et  al. 2014). 
For example, when not bound to its preferred ligand, 
1,25(OH)2D, VDR has been reported to associate with 
repressive chromatin remodelers including NCoR1, 
SMRT/NCoR2 and HDACs (Malinen et  al. 2008). This 
would suggest that VDD might create an environment 
that is conducive to repressive epigenetic effects. On the 
other hand, supplementation in colon cancer cell lines 
led to increased expression of JMJD3/KDM6B, which 
demethylates repressive H3K27me2/3 marks (Pereira 
et al. 2011). However, since global H3K27me3 levels were 
unchanged (Pereira et  al. 2012), functional impact on 
histone modifications is unclear. Vitamin D has also been 
proposed to mediate CTCF-dependent chromatin activity 
since supplementation in a human leukemic monocyte 
line (THP-1) caused transient genome-wide changes 
in chromatin accessibility at 8979 loci, 14% of which 
overlapped CTCF-binding sites (Seuter et al. 2016).
Conclusions
The current animal and human data provide robust 
evidence that VDD during development exerts important 
effects on later offspring neurobehavioral and metabolic 
health. Furthermore, these studies demonstrate the 
effectiveness of rodent models and potential for emerging 
zebrafish models as valuable tools poised to answer key 
mechanistic questions about developmental time points 
and in target tissues inaccessible in most human studies. 
To pinpoint how VDD affects individual organs such as 
the brain, development of conditional genetic models 
(e.g., VDR-Cre) in rodents and zebrafish will be useful. 
Epigenetic mechanisms present a promising link between 
VDD and offspring metabolic and neurobehavioral health 
outcomes (Fig.  2). Characterizing the impact of VDD-
induced epigenetic changes in the genome is important 
for understanding and developing potential preventative/
treatment measures to address VDD-induced effects. The 
mechanism by which maternal VDD alters offspring 
epigenetic status and physiological impact of such 
epigenetic modifications remains uncertain. Nonetheless, 
human and rodent studies strongly support the role 
of vitamin D as an effector of DNA methylation with 
potential dose-dependent effects (Zhu et al. 2016) and the 
ability to rescue methylation-dependent developmental 
phenotypes (Liu et al. 2017). Future studies are needed to 
elucidate windows of susceptibility, effective timing for 
intervention by supplementation and genetic population-
specific differences in susceptibility. Furthermore, 
although we have alluded to the impact of VDD on 
offspring as a direct effect, the indirect role of maternal/
intrauterine effects and adverse pregnancy outcomes are 
also important considerations.
In conclusion, VDD critically affects developmental 
programming of short- and long-term offspring metabolic 
and neurobehavioral health, potentially via epigenetic 
mechanisms. Whether these effects are due to canonical 
non-genomic or genomic actions of vitamin D remains 
unclear. Understanding causal mechanisms leading 
to adverse health in sons and daughters born to VDD 
mothers is essential for early diagnoses and improving 
treatment during pregnancy to prevent later adverse 
DOHaD effects in at-risk offspring.
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